tiprankstipranks
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF

Appili Therapeutics Inc Class A (APLIF) Stock Price & Analysis

81 Followers

APLIF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.02 - $0.08
Previous Close$0.02
Volume28.02K
Average Volume (3M)161.80K
Market Cap
$2.68M
Enterprise Value$8.13M
Total Cash (Recent Filing)C$602.88K
Total Debt (Recent Filing)C$8.01M
Price to Earnings (P/E)-0.7
Beta0.32
Jun 26, 2024
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding121,266,120
10 Day Avg. Volume11,725
30 Day Avg. Volume161,802
Standard Deviation0.27
R-Squared0.00331
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.37
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio2.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

4.43%0.00%0.00%95.57%
0.00% Other Institutional Investors
95.57% Public Companies and
Individual Investors

APLIF FAQ

What was Appili Therapeutics Inc Class A’s price range in the past 12 months?
Appili Therapeutics Inc Class A lowest stock price was $0.02 and its highest was $0.07 in the past 12 months.
    What is Appili Therapeutics Inc Class A’s market cap?
    Currently, no data Available
    When is Appili Therapeutics Inc Class A’s upcoming earnings report date?
    Appili Therapeutics Inc Class A’s upcoming earnings report date is Jun 26, 2024 which is in 89 days.
      How were Appili Therapeutics Inc Class A’s earnings last quarter?
      Appili Therapeutics Inc Class A released its earnings results on Feb 13, 2024. The company reported $0 earnings per share for the quarter, beating the consensus estimate of -$0.007 by $0.007.
        Is Appili Therapeutics Inc Class A overvalued?
        According to Wall Street analysts Appili Therapeutics Inc Class A’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Appili Therapeutics Inc Class A pay dividends?
          Appili Therapeutics Inc Class A does not currently pay dividends.
          What is Appili Therapeutics Inc Class A’s EPS estimate?
          Appili Therapeutics Inc Class A’s EPS estimate is >-$0.01.
            How many shares outstanding does Appili Therapeutics Inc Class A have?
            Appili Therapeutics Inc Class A has 121,266,120 shares outstanding.
              What happened to Appili Therapeutics Inc Class A’s price movement after its last earnings report?
              Appili Therapeutics Inc Class A reported an EPS of $0 in its last earnings report, beating expectations of -$0.007. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Appili Therapeutics Inc Class A?
                Currently, no hedge funds are holding shares in APLIF
                ---

                Appili Therapeutics Inc Class A Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -25.80%
                12-Months-Change

                Fundamentals

                Return on Equity
                Trailing 12-Months
                Asset Growth
                -21.84%
                Trailing 12-Months

                Company Description

                Appili Therapeutics Inc Class A

                Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Benitec Biopharma
                FibroGen
                Onconova Therapeutics
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis